REPORTING & DISCLOSURE TRACKING OUR PROGRESS DOW | REPORTING & DISCLOSURE | 195 Dow Disclosures – SASB Disclosure Report Community Relations RT-CH-210a.1. Discussion of engagement processes to manage risks and opportunities associated with community See disclosure GRI 102-43 Approach to stakeholder engagement. Workforce Health & Safety RT-CH-320a.1. (1) Total recordable incident rate (TRIR) and (2) fatality rate for (a) direct employees and (b) contract employees See disclosure GRI 403-9 Work-related injuries. RT-CH-320a.2. Description of efforts to assess, monitor and reduce exposure of employees and contract workers to long-term (chronic) health risks See disclosure GRI 403-3 Occupational health services. Product Design for Use-phase Efficiency RT-CH-410a.1. Revenue from products designed for use-phase resource efficiency See TCFD metrics – Dow Products and Services Revenue from Sustainable Products disclosure. Safety & Environmental Stewardship of Chemicals RT-CH-410b.1. (1) Percentage of products that contain Globally Harmonized System of Classification and Labeling of Chemicals (GHS) Category 1 and 2 Health and Environmental Hazardous Substances, (2) percentage of such products that have undergone a hazard assessment Dow tracks sales of products containing hazardous substances and ensures that all products are managed and used in line with their hazard profile. 100% of Dow products outlined in the SASB-identified categories undergo human and environmental toxicological risk assessments. Many of Dow’s products in the noted categories are basic building block chemistries that are used in closed, industrial processes to lower overall risk of exposure before being converted via chemical reaction to non-hazardous products. RT-CH-410b.2. Discussion of strategy to (1) manage chemicals of concern and (2) develop alternatives with reduced human and/or environmental impact See disclosure GRI 416-103 and the narrative on the Safer Materials focus area. Genetically Modified Organisms RT-CH-410c.1. Percentage of products by revenue that contain genetically modified organisms (GMOs) Dow does not manufacture any materials directly from genetically modified organisms (GMOs). However, Dow may use purchased raw materials derived from plant material, and that plant-based material may be genetically modified.